66 related articles for article (PubMed ID: 38532312)
21. Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids.
Khan AQ; Rashid K; AlAmodi AA; Agha MV; Akhtar S; Hakeem I; Raza SS; Uddin S
Biomed Pharmacother; 2021 Nov; 143():112142. PubMed ID: 34536761
[TBL] [Abstract][Full Text] [Related]
22. Relationship between genetically determined telomere length and glioma risk.
Saunders CN; Kinnersley B; Culliford R; Cornish AJ; Law PJ; Houlston RS
Neuro Oncol; 2022 Feb; 24(2):171-181. PubMed ID: 34477880
[TBL] [Abstract][Full Text] [Related]
23. Molecular Pathology of Gliomas.
Galbraith K; Snuderl M
Surg Pathol Clin; 2021 Sep; 14(3):379-386. PubMed ID: 34373090
[TBL] [Abstract][Full Text] [Related]
24. Human TERT promoter mutations as a prognostic biomarker in glioma.
Powter B; Jeffreys SA; Sareen H; Cooper A; Brungs D; Po J; Roberts T; Koh ES; Scott KF; Sajinovic M; Vessey JY; de Souza P; Becker TM
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1007-1017. PubMed ID: 33547950
[TBL] [Abstract][Full Text] [Related]
25. RTEL1 Regulates G4/R-Loops to Avert Replication-Transcription Collisions.
Kotsantis P; Segura-Bayona S; Margalef P; Marzec P; Ruis P; Hewitt G; Bellelli R; Patel H; Goldstone R; Poetsch AR; Boulton SJ
Cell Rep; 2020 Dec; 33(12):108546. PubMed ID: 33357438
[TBL] [Abstract][Full Text] [Related]
26. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Ningarhari M; Caruso S; Hirsch TZ; Bayard Q; Franconi A; Védie AL; Noblet B; Blanc JF; Amaddeo G; Ganne N; Ziol M; Paradis V; Guettier C; Calderaro J; Morcrette G; Kim Y; MacLeod AR; Nault JC; Rebouissou S; Zucman-Rossi J
J Hepatol; 2021 May; 74(5):1155-1166. PubMed ID: 33338512
[TBL] [Abstract][Full Text] [Related]
27. Overview of prognostic factors in adult gliomas.
Sharma A; Graber JJ
Ann Palliat Med; 2021 Jan; 10(1):863-874. PubMed ID: 32787379
[TBL] [Abstract][Full Text] [Related]
28. SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations.
Takedachi A; Despras E; Scaglione S; Guérois R; Guervilly JH; Blin M; Audebert S; Camoin L; Hasanova Z; Schertzer M; Guille A; Churikov D; Callebaut I; Naim V; Chaffanet M; Borg JP; Bertucci F; Revy P; Birnbaum D; Londoño-Vallejo A; Kannouche PL; Gaillard PHL
Nat Struct Mol Biol; 2020 May; 27(5):438-449. PubMed ID: 32398829
[TBL] [Abstract][Full Text] [Related]
29. Telomere-related Markers for Cancer.
Yuan X; Dai M; Xu D
Curr Top Med Chem; 2020; 20(6):410-432. PubMed ID: 31903880
[TBL] [Abstract][Full Text] [Related]
30. Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells.
Liu X; Zhao P; Wang X; Wang L; Zhu Y; Song Y; Gao W
J Exp Clin Cancer Res; 2019 May; 38(1):184. PubMed ID: 31053160
[TBL] [Abstract][Full Text] [Related]
31. Telomere Biology and Human Phenotype.
Turner KJ; Vasu V; Griffin DK
Cells; 2019 Jan; 8(1):. PubMed ID: 30669451
[TBL] [Abstract][Full Text] [Related]
32. ROS and the DNA damage response in cancer.
Srinivas US; Tan BWQ; Vellayappan BA; Jeyasekharan AD
Redox Biol; 2019 Jul; 25():101084. PubMed ID: 30612957
[TBL] [Abstract][Full Text] [Related]
33. Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk.
Rachakonda S; Kong H; Srinivas N; Garcia-Casado Z; Requena C; Fallah M; Heidenreich B; Planelles D; Traves V; Schadendorf D; Nagore E; Kumar R
Genes Chromosomes Cancer; 2018 Nov; 57(11):564-572. PubMed ID: 30203894
[TBL] [Abstract][Full Text] [Related]
34. Telomere length and survival in primary cutaneous melanoma patients.
Rachakonda S; Srinivas N; Mahmoudpour SH; Garcia-Casado Z; Requena C; Traves V; Soriano V; Cardelli M; Pjanova D; Molven A; Gruis N; Nagore E; Kumar R
Sci Rep; 2018 Jul; 8(1):10947. PubMed ID: 30026606
[TBL] [Abstract][Full Text] [Related]
35. Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia.
Bouillon AS; Ventura Ferreira MS; Awad SA; Richter J; Hochhaus A; Kunzmann V; Dengler J; Janssen J; Ossenkoppele G; Westerweel PE; Te Boekhorst PAW; Mahon FX; Hjorth-Hansen H; Isfort S; Fioretos T; Hummel S; Schemionek M; Wilop S; Koschmieder S; Saußele S; Mustjoki S; Beier F; Brümmendorf TH
Blood Adv; 2018 Jul; 2(13):1572-1579. PubMed ID: 29980572
[TBL] [Abstract][Full Text] [Related]
36. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
37. ROS signalling in the biology of cancer.
Moloney JN; Cotter TG
Semin Cell Dev Biol; 2018 Aug; 80():50-64. PubMed ID: 28587975
[TBL] [Abstract][Full Text] [Related]
38. Glioma Subclassifications and Their Clinical Significance.
Chen R; Smith-Cohn M; Cohen AL; Colman H
Neurotherapeutics; 2017 Apr; 14(2):284-297. PubMed ID: 28281173
[TBL] [Abstract][Full Text] [Related]
39. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.
; Haycock PC; Burgess S; Nounu A; Zheng J; Okoli GN; Bowden J; Wade KH; Timpson NJ; Evans DM; Willeit P; Aviv A; Gaunt TR; Hemani G; Mangino M; Ellis HP; Kurian KM; Pooley KA; Eeles RA; Lee JE; Fang S; Chen WV; Law MH; Bowdler LM; Iles MM; Yang Q; Worrall BB; Markus HS; Hung RJ; Amos CI; Spurdle AB; Thompson DJ; O'Mara TA; Wolpin B; Amundadottir L; Stolzenberg-Solomon R; Trichopoulou A; Onland-Moret NC; Lund E; Duell EJ; Canzian F; Severi G; Overvad K; Gunter MJ; Tumino R; Svenson U; van Rij A; Baas AF; Bown MJ; Samani NJ; van t'Hof FNG; Tromp G; Jones GT; Kuivaniemi H; Elmore JR; Johansson M; Mckay J; Scelo G; Carreras-Torres R; Gaborieau V; Brennan P; Bracci PM; Neale RE; Olson SH; Gallinger S; Li D; Petersen GM; Risch HA; Klein AP; Han J; Abnet CC; Freedman ND; Taylor PR; Maris JM; Aben KK; Kiemeney LA; Vermeulen SH; Wiencke JK; Walsh KM; Wrensch M; Rice T; Turnbull C; Litchfield K; Paternoster L; Standl M; Abecasis GR; SanGiovanni JP; Li Y; Mijatovic V; Sapkota Y; Low SK; Zondervan KT; Montgomery GW; Nyholt DR; van Heel DA; Hunt K; Arking DE; Ashar FN; Sotoodehnia N; Woo D; Rosand J; Comeau ME; Brown WM; Silverman EK; Hokanson JE; Cho MH; Hui J; Ferreira MA; Thompson PJ; Morrison AC; Felix JF; Smith NL; Christiano AM; Petukhova L; Betz RC; Fan X; Zhang X; Zhu C; Langefeld CD; Thompson SD; Wang F; Lin X; Schwartz DA; Fingerlin T; Rotter JI; Cotch MF; Jensen RA; Munz M; Dommisch H; Schaefer AS; Han F; Ollila HM; Hillary RP; Albagha O; Ralston SH; Zeng C; Zheng W; Shu XO; Reis A; Uebe S; Hüffmeier U; Kawamura Y; Otowa T; Sasaki T; Hibberd ML; Davila S; Xie G; Siminovitch K; Bei JX; Zeng YX; Försti A; Chen B; Landi S; Franke A; Fischer A; Ellinghaus D; Flores C; Noth I; Ma SF; Foo JN; Liu J; Kim JW; Cox DG; Delattre O; Mirabeau O; Skibola CF; Tang CS; Garcia-Barcelo M; Chang KP; Su WH; Chang YS; Martin NG; Gordon S; Wade TD; Lee C; Kubo M; Cha PC; Nakamura Y; Levy D; Kimura M; Hwang SJ; Hunt S; Spector T; Soranzo N; Manichaikul AW; Barr RG; Kahali B; Speliotes E; Yerges-Armstrong LM; Cheng CY; Jonas JB; Wong TY; Fogh I; Lin K; Powell JF; Rice K; Relton CL; Martin RM; Davey Smith G
JAMA Oncol; 2017 May; 3(5):636-651. PubMed ID: 28241208
[TBL] [Abstract][Full Text] [Related]
40. Association between telomere length and survival in cancer patients: a meta-analysis and review of literature.
Xu X; Qu K; Pang Q; Wang Z; Zhou Y; Liu C
Front Med; 2016 Jun; 10(2):191-203. PubMed ID: 27185042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
